ISS Pharmaceuticals, Inc.

is an early stage drug discovery research company focused on discovery of novel pharmaceutical products for diseases with high unmet medical need. Our most advanced program is in diseases associated with insulin resistance - type 2 diabetes, obesity, and metabolic syndrome.

Our research is focused on employing newer technologies to discover new molecules of therapeutic interest via gaining an understanding of the etiology of diseases at the molecular level. Our research is based on our strengths including our platform technology that employs systems biology analysis of genomics and proteomics data to gain insights into insulin resistance.